Fatty acid transport protein (FATP) 4 is one of a family of six FATPs that facilitate long-and very long-chain fatty acid uptake. Mice lacking FATP4 are born with tight, thick skin and a defective barrier; they die neonatally due to dehydration and restricted movements. Mutations in SLC27A4, the gene encoding FATP4, cause ichthyosis prematurity syndrome (IPS), characterized by premature birth, respiratory distress, and edematous skin with severe ichthyotic scaling. Symptoms of surviving patients become mild, though atopic manifestations are common. We previously showed that suprabasal keratinocyte expression of a Fatp4 transgene in Fatp4 mutant skin rescues the lethality and ameliorates the skin phenotype. Here we tested the hypothesis that FATP1, the closest FATP4 homolog, can compensate for the lack of FATP4 in our mouse model of IPS, as it might do postnatally in IPS patients. Transgenic expression of FATP1 in suprabasal keratinocytes rescued the phenotype of Fatp4 mutants, and FATP1 sorted to the same intracellular organelles as endogenous FATP4. Thus, FATP1 and FATP4 likely have overlapping substrate specificities, enzymatic activities, and biological functions. These results suggest that increasing expression of FATP1 in suprabasal keratinocytes could normalize the skin of IPS patients and perhaps prevent the atopic manifestations.
INTRODUCTION
Mammalian skin provides the first line of defense against mechanical, chemical, and biological assaults and functions as a barrier to inhibit water loss. The cutaneous permeability barrier is mediated by the most superficial, cornified epidermal layer that forms from a series of differentiation and stratification processes. At the beginning of epidermal differentiation, proliferative basal keratinocytes migrate suprabasally and switch from a keratins 5/14-containing network to a keratins 1/10-containing network, forming the spinous layer (Candi et al., 2005) . The granular layer above has profilaggrin-containing keratohyalin granules that facilitate the assembly of keratin bundles. Granulocytes form a cornified envelope beneath the cell membrane via the cross-linking of involucrin (IVL), loricrin, and other proteins (Candi et al., 2005) . The cornified layer consists of dead, flattened, interdigitating keratinocytes embedded in a lipid-rich matrix that results from secretion and processing of lipids from lamellar bodies in granulocytes (Breiden and Sandhoff, 2013) .
Fatty acids in either a complex lipid or a free form are crucial to the epidermal permeability barrier. Fatty acids serve as building blocks for the complex lipids necessary to form the permeability barrier, as signals for keratinocytes to regulate epidermal homeostasis, and as acidifiers of the cornified layer to promote its structural integrity and barrier function (Lin and Khnykin, 2013) . Fatty acids can be synthesized de novo by keratinocytes or taken up from the diet or from extracutaneous sites. Several proteins facilitate the uptake of longchain fatty acids in mammalian cells, including fatty acid translocase (Coburn et al., 2001; Furuhashi and Hotamisligil, 2008) , fatty acid binding protein (Furuhashi and Hotamisligil, 2008) , and members of the fatty acid transport protein/very long-chain acyl-CoA synthetase (FATP/ACSVL) family (Anderson and Stahl, 2013; Gimeno, 2007) . However, the exact molecular mechanism of transport across the plasma membrane remains unclear. Clinical findings and recent studies in animal models suggest crucial roles for these candidate transporters in the skin (Lin and Khnykin, 2013) .
The FATP family consists of six membrane proteins that can all facilitate uptake of fatty acids of 16 to 24 carbons (Coe et al., 1999; Hall et al., 2005; Jia et al., 2007; Mihalik et al., 2002) . FATPs display acyl-CoA synthetase (ACS) activity and are proposed to facilitate uptake of fatty acids by a mechanism called vectorial acylation, whereby free fatty acids are esterified into an acyl-CoA form after import, thus diminishing the intracellular pool of free fatty acids and creating a gradient across the membrane that drives their further influx (Black and DiRusso, 2003) . It is not known whether FATPs function as inherent transporters or whether a different protein is required to facilitate fatty acid import. The distribution of FATPs in the skin varies substantially: FATP1, FATP3, FATP4, and FATP6 are detected in the epidermis and hair follicles of adult mice; FATP1 and FATP4 are robustly expressed in subcutaneous fat; and FATP4 is the only FATP detected in sebaceous glands (Schmuth et al., 2005) .
We previously identified an autosomal recessive mouse phenotype called wrinkle free caused by a retrotransposon insertion into Slc27a4, the gene encoding FATP4 (Moulson et al., 2003) . Mice lacking FATP4 (herein referred to as Fatp4 −/− mice) are born with tight, thick, "wrinkle free" skin and a defective skin barrier, whereas Fatp4 +/− mice are phenotypically normal. Fatp4 −/− mice die neonatally due to dehydration and restricted movements. Similar phenotypes occur in two independently derived Fatp4 mutants (Herrmann et al., 2003; Tao et al., 2012) . Suprabasal keratinocyte expression of a Fatp4 transgene in Fatp4 mutant skin rescues the neonatal lethality and ameliorates the skin phenotype, underscoring the crucial, skin-intrinsic roles of FATP4 in skin development and function .
Mutations affecting human FATP4 occur in patients with ichthyosis prematurity syndrome (IPS), characterized by premature birth, respiratory distress, peripheral blood eosinophilia, and edematous skin with severe caseous scaling (Bygum et al., 2008; Klar et al., 2009; Sobol et al., 2011) . Symptoms of surviving patients become mild during childhood and manifest mainly as dry and pruritic skin, though respiratory and/or food allergies are common (Khnykin et al., 2012) . This suggests that FATP4 is critical for the development of skin during the fetal and neonatal periods, but other FATPs may compensate for the lack of FATP4 at later stages.
Here we tested the hypothesis that FATP1, the FATP with the highest homology to FATP4, can functionally compensate for the lack of FATP4. Our results demonstrate that transgenic FATP1 expression in suprabasal keratinocytes rescues the neonatal lethality and ameliorates the skin phenotype in Fatp4 mutants, similar to transgenic FATP4 expression.
RESULTS

Expression of Fatp4 and Fatp1 in fetal skin
By in situ hybridization, Fatp4 was normally expressed in fetal epidermis in suprabasal keratinocytes (upper left panel in Figure 1a ) and in hair follicle and sebaceous gland progenitors . In contrast, Fatp4 −/− mice showed nuclear localization of Fatp4 RNA in some epidermal keratinocytes, perhaps due to mislocalization of mutant transcripts caused by inclusion of the retrotransposon (upper middle panel in Figure 1a ) . FATP1 is the FATP with the highest homology to FATP4 (Hirsch et al., 1998) . Fatp1 RNA was detected in subsets of basal keratinocytes, in hair follicle progenitors (lower left panel in Figure 1a ), and in subcutaneous adipocytes (data not shown) during fetal development. Its epidermal expression did not appear to be affected by the lack of FATP4 (lower middle panel in Figure 1a ). Thus, Fatp4 and Fatp1 are expressed in nearly complementary compartments in fetal mouse skin.
Restoration of the skin barrier in Fatp4 −/− ;Tg(IVL-Fatp1) mice
We showed previously that suprabasal keratinocyte expression of a Fatp4 transgene in Fatp4 mutant skin rescues the neonatal lethality and ameliorates the skin phenotype, underscoring the crucial, skin-intrinsic roles of FATP4 in the development and function of skin . To test whether FATP1 can functionally compensate for the lack of FATP4 in our mouse model of IPS, we generated three independent lines of transgenic mice expressing a hemagglutinin (HA)-tagged FATP1 under the control of the human IVL promoter. After crossing to Fatp4 +/− mice for two generations, Fatp4 −/− ;Tg(IVL-Fatp1) mice were obtained. Fatp4 −/− ;Tg(IVL-Fatp1) mice derived from two of the transgenic lines were viable and fertile and showed robust Fatp1 transgene expression in suprabasal keratinocytes (lower right panel in Figure 1a ). While Fatp1 RNA in early hair follicle progenitors was decreased in Fatp4 −/− ;Tg(IVL-Fatp1) skin (lower right panel in Figure 1a ), its expression in more differentiated follicles was not changed (not shown). Like Fatp4 −/− ;Tg(IVL-Fatp4) mice , Fatp4 −/− ;Tg(IVL-Fatp1) mice also displayed disheveled coat hair as early as around weaning age, which progressed into thinning hair and/or patches of alopecia at older ages (data not shown). Fatp4 −/− mice rescued by either of the two IVL-Fatp1 lines showed similar results; data obtained from one line are shown here. Fatp4 −/− ;Tg(IVL-Fatp1) mice from the third line died postnatally due to transgene expression in only a subset of granular cells (data not shown).
Fatp4 −/− mice exhibit an abnormal permeability barrier from E16.5 onwards and show an incomplete barrier at birth; these barrier defects are remedied by expression of a Fapt4 transgene in suprabasal keratinocytes (Lin et al., 2010; Moulson et al., 2007) . As assayed by the inward permeability of X-Gal, forced FATP1 expression in the epidermis was also able to normalize the defective barrier of Fatp4 −/− fetuses ( Figure 1b) . Moreover, Fatp4 −/− newborns showed a significantly higher outward transepidermal water loss (TEWL) than Fatp4 +/− controls (5.3±1.6 g/m 2 h, n=9 vs. 1.1±0.9 g/m 2 h, n=4; ***P<0.001) (Figure 1c 
Amelioration of skin phenotypes in Fatp4 −/− ;Tg(IVL-Fatp1) mice
Fatp4 −/− fetuses display epidermal hyperplasia that results from an increased number of proliferating suprabasal cells (Lin et al., 2010) . The hyperplasia is associated with epidermal activation of keratin 6 expression, epidermal growth factor receptor (EGFR) signaling, and phosphorylation and nuclear translocation of STAT3, a downstream effector of EGFR signaling. Pharmacological inhibition of EGFR and STAT3 activation reduce skin thickening and partially suppress the barrier abnormalities (Lin et al., 2010) . Consistent with the RNA expression pattern of the Fatp1 transgene, HA-tagged FATP1 was detected specifically in suprabasal keratinocytes (second row in Figure 2 ). The transgenic FATP1 prevented the epidermal hyperplasia observed in Fatp4 −/− mice (top row in Figure 2 ). In addition, the ectopic activation of keratin 6 and STAT3 in Fatp4 −/− epidermis was diminished by Fatp1 transgene expression (bottom two rows in Figure 2 ). This amelioration of Fatp4 −/− skin phenotypes is reminiscent of the effects of suprabasal Fatp4 transgene expression .
Amelioration of lipid abnormalities in Fatp4 −/− ;Tg(IVL-Fatp1) epidermis
FATP4 is normally localized to the granular layer of the epidermis, where barrier lipid precursors are synthesized. During epidermal differentiation, the lipid-enriched contents of lamellar bodies in the uppermost cells of the granular layer are secreted into the extracellular space and processed into ceramides, cholesterol, and fatty acids, the three major lipids required for permeability barrier function of the cornified layer (Holleran et al., 2006) . Epidermal lipid analyses of Fatp4 mutant newborns revealed a significantly decreased proportion of ceramides with fatty acid moieties containing 26 or more carbon atoms and a significantly increased proportion of those containing 24 or fewer carbon atoms (Herrmann et al., 2003; Moulson et al., 2007) . These ceramide abnormalities suggest an inability of Fatp4 mutant keratinocytes to activate very long-chain fatty acids to an acyl-CoA form, which could lead to subsequent accumulation of free fatty acids inside cells.
To investigate this hypothesis, we performed lipid analyses by thin layer chromatography (TLC) using total free, extractable lipids isolated from newborn epidermis. Compared to controls, Fatp4 −/− epidermis showed a significantly increased amount of free fatty acids (Figure 3) . Quantification of free fatty acids in separate studies revealed 4.44 ± 0.82 μg/mg dry tissue in controls (n=4) vs. 8.80 ± 1.75 μg/mg in mutants (n=4), P<0.01 (Table S1a) ; and 3.96 ± 1.06 μg/mg dry tissue in controls (n=6) vs. 6.54 ± 0.82 μg/mg in mutants (n=6), P<0.001 (Table S1b) . Furthermore, these increases were ameliorated in both Fatp4 −/− ;Tg(IVL-Fatp1) mice (Figure 3a and Table S1a ) and Fatp4 −/− ;Tg(IVL-Fatp4) mice ( Figure 3b and Table S1b ). In contrast, the levels of cholesteryl ester, triacyglycerol, and free cholesterol in the newborn epidermis were not significantly affected by FATP4 deficiency (Figure 3 and Table S1 ).
Subcellular localization of endogenous FATP4 and transgenic FATP1 in the epidermis
The subcellular localization of FATP1 and FATP4 in mammalian cells has been reported to be plasma membrane and/or intracellular organelles (Kazantzis and Stahl, 2012 and references therein). For example, studies of stably transfected FATP4-overexpressing cells suggest that FATP4 is an endoplasmic reticulum (ER)-localized ACS that is able to drive import of fatty acids via its enzymatic activity (Milger et al., 2006; Zhan et al., 2012) . Our previous study of cultured fibroblasts shows that endogenous FATP4 is localized to mitochondria and to a lesser extent to ER and peroxisomes (Jia et al., 2007) . To examine whether endogenous FATP4 is also localized to multiple organelles in the epidermis, granular keratinocytes, which show the most intense FATP4 immunostaining , were isolated from newborn and young pup skin and analyzed.
By hematoxylin staining, granular keratinocytes isolated from control mice were filled with keratohyalin granules (lower left panel in Figure 4 ). Compared to controls, granular keratinocytes from Fatp4 −/− newborns were smaller, and the granules were less distinct (middle column in Figure 4 ). In contrast, these abnormalities were remedied in Fatp4 −/− ;Tg(IVL-Fatp4) cells and Fatp4 −/− ;Tg(IVL-Fatp1) cells (right column in Figure 4) . By double immunofluorescence staining, endogenous FATP4 in control cells was detected in a mesh-like pattern that colocalized mainly with the ER luminal protein calreticulin (Figure 5d -f′) and partially with the mitochondrial membrane protein ATP synthase (Figure  5a -c′; arrowheads in c′). The FATP4 signals were also observed at the nuclear surface, which is very likely the ER membrane that is contiguous with the nuclear membrane. Using interleukin 1 receptor 1 as a marker, we could not detect FATP4 at the plasma membrane (Figure 5g-i′) . The mesh-like pattern of FATP4 staining was similar to the inter-granular staining of calreticulin (Figure 5j As demonstrated above, transgenic expression of FATP1 in suprabasal keratinocytes rescued the Fatp4−/− neonatal lethality and normalized most of the skin abnormalities. To examine whether the rescuing effects of exogenous FATP1 correlated with its trafficking to the same subcellular compartments as endogenous FATP4, granular keratinocytes from Fatp4 +/+ ;Tg(IVL-Fatp1) mice were subjected to double immunofluorescence staining with HA-tag and FATP4 antibodies. As shown in Figure 5s -u′, HA-tagged transgenic FATP1 colocalized nearly completely with endogenous FATP4. This implies localization of transgenic FATP1 to ER and mitochondria but not to the plasma membrane, as observed for FATP4. This observation was confirmed by double immunofluorescence staining in Fatp4 −/− ;Tg(IVL-Fatp1) cells with HA-tag antibody and various organellar marker antibodies ( Figure S1 ). These results suggest that the rescuing effects of HA-FATP1 require its sorting to the same subcellular compartments as FATP4.
DISCUSSION
Among the six mouse FATP family members, FATP1 is most closely related to FATP4 (Herrmann et al., 2001) . These two FATPs are expressed in nearly complementary compartments in the skin during fetal development: FATP4 in suprabasal keratinocytes, sebaceous gland progenitors, and hair follicle progenitors , and FATP1 in cell clusters within the basal layer of the epidermis, in adipocytes of subcutaneous fat, and in hair follicle progenitors (Figure 1 ). Unlike Fatp4 −/− mice, knockout of Fatp1 does not lead to skin phenotypes, despite its cutaneous expression pattern (Kim et al., 2004) . In addition, although FATP4 expression predominates in fetal mouse epidermis, FATP1 expression predominates in adult epidermis (Schmuth et al., 2005) . The spatial and temporal differences in expression of these two FATPs in the skin suggest regulation to meet the metabolic requirements of various compartments and developmental stages.
Our results demonstrate that transgenic expression of FATP1 in suprabasal keratinocytes of Fatp4 −/− mice, like that of FATP4, rescues the neonatal lethality and normalizes the permeability barrier, epidermal hyperplasia, the level of free fatty acids, epidermal activation of keratin 6 and STAT3, and defective keratohyalin granules. The subcellular localization of FATP1 and FATP4 in mammalian cells has been reported to be plasma membrane and/or intracellular organelles (Kazantzis and Stahl, 2012 and references therein). However, our results show that endogenous FATP4 in epidermal keratinocytes is localized to the ER and mitochondria, but not to the plasma membrane. This suggests that in epidermal keratinocytes FATP4 does not function as a transmembrane transporter per se, but rather facilitates fatty acid import indirectly by activating fatty acids to an acyl-CoA form. Studies using FATP4-overexpressing cells suggest that FATP4 is an ER-localized ACS that displays a type III signal-anchor transmembrane domain topology, with the short N-terminal sequence of FATP4 oriented toward the ER lumen and the enzymatic part facing the cytosolic side (Milger et al., 2006; Zhan et al., 2012) . It remains unknown how the information in FATP4 regulates its targeting in epidermal keratinocytes to the ER and to the mitochondria, but our results show that exogenous FATP1 was sorted to these same granular keratinocyte subcellular compartments.
Our preliminary mass spectrometry data show that the elevated free fatty acid pool in Fatp4 −/− epidermis ( Figure 3 ) was composed of VLCFA, especially C22:0, C24:0, C24:1, and C26:1. The increases in these VLCFA were normalized by both Fatp1 and Fatp4 transgenes (unpublished data). Taken together, that FATP1 could functionally compensate for the FATP4 deficiency in Fatp4 −/− skin indicates that FATP1 and FATP4 likely share similar substrate specificities and enzymatic activities. The presence of both genes in the mammalian genome could relate to their partially non-overlapping expression patterns rather than to any significant functional differences.
As in adult mouse epidermis, FATP1, -3, -4, and -6 are also expressed in human epidermis. Upon barrier disruption in adult mice, the epidermal expression of FATP6 and fatty acid translocase, another candidate transporter that facilitates the uptake of fatty acids in the epidermis, is increased. This upregulation suggests potential roles for FATPs in restoring the steady state of barrier lipids (Schmuth et al., 2005) . It would be important to investigate whether in IPS patients other FATPs or other candidate transporters are ectopically expressed in the same epidermal compartments as endogenous FATP4 after birth to compensate for the skin abnormalities. Given the functional similarities between FATP1 and FATP4 revealed by our mouse studies, increasing expression of FATP1/SLC27A1 in suprabasal keratinocytes could be pursued as a therapy to normalize the skin phenotype of IPS patients and perhaps prevent the development of atopic manifestations. Our results in mice also suggest that the amelioration of symptoms in IPS patients postnatally might be attributable to postnatal ectopic expression of FATP1 in the cell layer where endogenous FATP4 is normally expressed. In Fatp4 mutant mice, the epidermal expression of Fatp1 RNA during fetal development (Figure 1 ) or at birth (data not shown) did not appear to be increased by the lack of FATP4, perhaps explaining their severe skin phenotype.
MATERIALS AND METHODS
Mice
Fatp4 mutant and IVL promoter-driven Fatp4 transgenic mice have been previously described Moulson et al., 2003) . The human IVL promoter-driven Fatp1 transgene was generated by PCR amplification of a cDNA encoding FATP1 with an amino-terminal hemagglutinin (HA)-tag (Chiu et al., 2005) using Klentaq LA DNA polymerase (in-house facility of Washington University) and primers that added NotI sites to the HA-tag and to the 3′ end of the cDNA. The PCR product was purified by the Wizard SV Gel and PCR CleanUp System (Promega, Madison, WI), cut with NotI, and ligated into the NotI sites of a clone containing the human IVL promoter and the SV40 polyadenylation signal sequence (Carroll et al., 1993) . The transgene was liberated from the vector by digestion with SalI and purified by the QIAEX II Gel Extraction Kit (Qiagen, Germantown, MD). Transgenic mice were generated by microinjection of the transgene into the pronuclei of one-cell stage B6CBAF2/J mouse embryos. Potential founders were screened for incorporation of the transgene by PCR using primers from two different exons of Fatp1 and examined for expression of the transgene by immunohistochemistry with an HA tag antibody (see below). Embryos were dissected from pregnant females, with the morning when the copulation plug was observed considered embryonic day (E) 0.5. All experiments were approved by the Washington University Animal Studies Committee.
Skin barrier assays
Inward permeability assay by X-Gal and outward TEWL assay with a Vapometer were performed as described (Lin et al., 2010) .
Immunohistochemistry
Immunohistochemical analyses on paraffin sections were performed as described (Lin et al., 2010) . The antigen retrieval method and dilutions of primary antibodies used were as follows: EDTA and 1:50 for phospho-STAT3 (Tyr705); Trilogy and 1:50 for HA tag (both antibodies from Cell Signaling Technology, Beverly, MA); and 1:1,000 for keratin 6 (Covance, Princeton, NJ). Sections were counterstained with hematoxylin and mounted.
In situ hybridization
Preparation of paraffin sections and in situ hybridization using digoxigenin-UTP labeled Fatp4 and Fatp1 riboprobes were performed as described , with the hybridization temperature at 60°C and 55°C, respectively.
Extraction of epidermal lipids
HPLC grade solvents were purchased from Sigma Chemical Co. (St. Louis, MO). Free, extractable lipids were isolated from the epidermis of newborn mice. To isolate the epidermis, the body trunk skin was incubated in 10 mM EDTA in PBS at 37°C for 1.5 h with the dermal side down. The epidermis was peeled as a whole sheet, lyophilized, weighed, and stored at −80°C. Lipids were extracted from lyophilized epidermis of each newborn with 3.8 ml of chloroform/methanol/water (1/2/0.8) at room temperature for 2 h followed by phase separation by adding 1 ml each of chloroform and water. After centrifugation, the lipid-enriched lower phase was reextracted with 1 ml of chloroform, 1 ml of methanol, and 0.9 ml of water and recentrifuged. The lower phase was then dried with a nitrogen evaporator (Organomation Associates, Inc., Berlin, MA), resuspended in 200 μl chloroform/methanol (2/1), and stored under nitrogen at −20°C.
Lipid analysis by TLC
Silica gel 60 plates (Sigma; Merck, Germany) were baked at 120°C for 30 min in an oven prior to use. To separate neutral lipids, lipid extracts were applied to plates and resolved in a solvent mixture of hexane/diethyl ether/acetic acid (70:30:1) in a pre-equilibrated tank until the solvent front reached the top of the plate (20 cm). Standard lipids used include the nonpolar lipid mix B, palmitic acid (16:0) (both from Matreya LLC, Pleasant Gap, PA), heptacosanoic acid (27:0), and a mono-, di-, triglyceride mix (both from Sigma). Resolved plates were dried, and the lipid spots were visualized by spraying with 3% copper acetate in 8% phosphoric acid followed by charring at 180°C for 15 min in an oven (Macala et al., 1983) . For quantification of lipid species, lipid spots on charred TLC plates were scanned and quantified in ImageJ (http://rsbweb.nih.gov/ij/) with co-chromatographed standards in the range of 0.5 to 4 μg for each band. Cholesteryl oleate, triolein, and oleic acid were used as the standards for cholesteryl ester, triacylglycerol, and free fatty acids, respectively.
Isolation of keratinocyte fractions
The epidermis was collected from newborn mice and young pups up to 5.5 days of age as described above. For newborns, the basal and spinous keratinocytes-enriched fraction was obtained by incubating the epidermis in 0.05% trypsin-EDTA (Gibco, Grand Island, NY) at 37°C for 20 min in a small dish with the skin surface up followed by manually shaking the digested epidermis in cold PBS vigorously 20 times and filtering through a 70-μm nylon cell strainer (BD Biosciences, San Jose, NJ) into a tube containing cold soy bean trypsin inhibitor (Gibco) at 0.5 mg/ml in PBS. The granular keratinocytes-enriched fraction was obtained by incubating the residual epidermal sheet in 0.25% trypsin-EDTA (Gibco) at 37°C for 20 min in a small dish with the skin surface up followed by manually shaking the digested sheet in cold trypsin inhibitor solution vigorously 20 times and filtering through a 100-μm nylon cell strainer (BD Biosciences). Both cell fractions were then centrifuged at 800 rpm for 5 min at 4°C, resuspended in cold PBS, and spun onto slides at 400 rpm for 3 min in a Shandon Cytospin (Thermo Scientific, Rockford, IL) to make a cell monolayer. Slides were air dried for 10 min and stored at −20°C for up to a week.
Immunofluorescence staining
The cell monolayers were fixed in 4% paraformaldehyde in PBS for 5 min, permeabilized with cold methanol at −20°C for 5 min, and blocked in 1% bovine serum albumin and 10% normal goat serum or normal donkey serum in PBS for 30 min. Cells were then incubated at 4°C overnight with primary antibodies diluted in 1% bovine serum albumin in PBS, incubated for 30 min in dark with fluorophore-labeled secondary antibodies diluted in 1% bovine serum albumin in PBS, counterstained with Hoechst 33258, and mounted in 90% glycerol containing 0.1X PBS and 1 mg/ml p-phenylenediamine. Immunostaining with filaggrin antibody was performed on freshly prepared cell monolayers by fixation in 4% paraformaldehyde in PBS for 20 min and permeabilization in 0.5% Triton X-100 in PBS for 5 min. Dilutions of primary antibodies used were as follows: 1:100 for FATP4 (Newberry et al., 2003) , calreticulin/calregulin (Santa Cruz Biotechnology, Santa Cruz, CA), ATP synthase, beta chain (Millipore, Temecula, CA), and interleukin 1 receptor 1 (R&D Systems, Minneapolis, MN); 1:4000 for filaggrin and 1:50 for mouse HA-tag (Covance, Princeton, NJ); 1:50 for rabbit HA-tag (Cell Signaling Technology, Beverly, MA). Fluorophoreconjugated secondary antibodies were used at a 1:400 dilution and included the following: goat Alexa 488 anti-rabbit; goat Cy3 anti-mouse (both from Invitrogen); donkey Alexa 488 anti-rabbit; donkey Cy3 anti-goat (both from Jackson Immunoresearch, West Grove, PA). Images were acquired with a Nikon C1 confocal system (Nikon Instruments, Melville, NY) and analyzed in Nikon Elements software (Nikon). 
